Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2018, Article ID 5356245, 7 pages
https://doi.org/10.1155/2018/5356245
Research Article

Frequency of Red Blood Cell Alloimmunization in Patients with Sickle Cell Disease in Palestine

1Department of Medical Technology, Faculty of Allied Health Sciences, Arab American University in Jenin, State of Palestine
2Department of Biology and Biochemistry, Faculty of Science, Birzeit University, Birzeit, State of Palestine
3Rafidia Governmental Hospital, Ministry of Health, Nablus, State of Palestine

Correspondence should be addressed to Fekri Samarah; ude.juaa@haramas.irkef

Received 27 February 2018; Revised 2 May 2018; Accepted 9 May 2018; Published 6 June 2018

Academic Editor: Maria Rios

Copyright © 2018 Fekri Samarah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Weatherall and J. B. Clegg, “Inherited haemoglobin disorders: an increasing global health problem,” Bulletin of the World Health Organization, vol. 79, no. 8, pp. 704–712, 2001. View at Google Scholar · View at Scopus
  2. Thalassemia Patients’ Friends Society, Thalassemia: Treatment Guidelines for Patients. Al-Bireh, Palestine , 2014 (Arabic).
  3. Palestinian Central Bureau of Statistics, http://www.pcbs.gov.ps/site/lang__en/881/default.aspx?lang=en.
  4. H. Darwish, F. El-Khatib, and S. Ayesh, “Spectrum of β-globin gene mutations among thalassemia patients in the west bank region of palestine,” Hemoglobin, vol. 29, no. 2, pp. 119–132, 2005. View at Publisher · View at Google Scholar
  5. F. Samarah, S. Ayesh, M. Athanasiou, J. Christakis, and N. Vavatsi, “βs-globin gene cluster haplotypes in the west bank of palestine,” Hemoglobin, vol. 33, no. 2, pp. 143–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin, “The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease,” The Journal of the American Medical Association, vol. 293, no. 13, pp. 1653–1662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Stuart and R. L. Nagel, “Sickle-cell disease,” The Lancet, vol. 364, no. 9442, pp. 1343–1360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. O. S. Platt, D. J. Brambilla, W. F. Rosse et al., “Mortality in sickle cell disease. Life expectancy and risk factors for early death,” The New England Journal of Medicine, vol. 330, no. 23, pp. 1639–1644, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. C. D. Josephson, L. L. Su, K. L. Hillyer, and C. D. Hillyer, “Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines,” Transfusion Medicine Reviews, vol. 21, no. 2, pp. 118–133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. C. Desai, A. M. Deal, E. R. Pfaff et al., “Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease,” American Journal of Hematology, vol. 90, no. 8, pp. 691–695, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. S. O. Wanko and M. J. Telen, “Transfusion management in sickle cell disease,” Hematology/Oncology Clinics of North America, vol. 19, no. 5, pp. 803–826, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. T. Chou, T. Jackson, S. Vege, K. Smith-Whitley, D. F. Friedman, and C. M. Westhoff, “High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors,” Blood, vol. 122, no. 6, pp. 1062–1071, 2013. View at Publisher · View at Google Scholar
  13. U. Kangiwa, O. Ibegbulam, S. Ocheni, A. Madu, and N. Mohammed, “Pattern and prevelence of alloimmunization in multiply transfused patients with sickle cell disease in Nigeria,” Biomarker Research, vol. 3, article 26, 2015. View at Publisher · View at Google Scholar
  14. W. F. Rosse, D. Gallagher, T. R. Kinney et al., “Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease,” Blood, vol. 76, no. 7, pp. 1431–1437, 1990. View at Google Scholar · View at Scopus
  15. E. P. Vichinsky, A. Earles, R. A. Johnson, M. S. Hoag, A. Williams, and B. Lubin, “Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood,” The New England Journal of Medicine, vol. 322, no. 23, pp. 1617–1621, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Natukunda, H. Schonewille, C. Ndugwa, and A. Brand, “Red blood cell alloimmunization in sickle cell disease patients in Uganda,” Transfusion, vol. 50, no. 1, pp. 20–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Schonewille, L. M. G. Van De Watering, D. S. E. Loomans, and A. Brand, “Red blood cell alloantibodies after transfusion: Factors influencing incidence and specificity,” Transfusion, vol. 46, no. 2, pp. 250–256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Higgins and S. R. Sloan, “Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders,” Blood, vol. 112, no. 6, pp. 2546–2553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Pathare and S. Alkindi, “Alloimmunization in patients with sickle cell disease and thalassaemia: experience of single centre from oman,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 9, no. 1, 2017. View at Publisher · View at Google Scholar
  20. R. G. Schneider, “Differentiation of electrophoretically similar hemoglobins— such as S, D, G and P; or A2, C, E, and O by electrophoresis of the globin chains,” Clinical Chemistry, vol. 20, pp. 1111–1115, 1974. View at Google Scholar
  21. A. E. Kulozik, J. Lyons, E. Kohne, C. R. Bartram, and E. Kleihauer, “Rapid and non-radioactive prenatal diagnosis of β thalassaemia and sickle cell disease: application of the polymerase chain reaction (PCR),” British Journal of Haematology, vol. 70, no. 4, pp. 455–458, 1988. View at Publisher · View at Google Scholar
  22. S. Asma, I. Kozanoglu, E. Tarım et al., “Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy,” Transfusion, vol. 55, no. 1, pp. 36–44, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Bashawri, “Red cell alloimmunization in sickle-cell anaemia patients,” Eastern Mediterranean Health Journal, vol. 13, no. 5, pp. 1181–1189, 2007. View at Publisher · View at Google Scholar
  24. R. Aly, M. R. El-sharnoby, and A. A. Hagag, “Frequency of red cell alloimmunization in patients with sickle cell anemia in an Egyptian referral hospital,” Transfusion and Apheresis Science, vol. 47, no. 3, pp. 253–257, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Ameen, S. Al Shemmari, and A. Al-Bashir, “Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion,” Transfusion, vol. 49, no. 8, pp. 1649–1654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Olujohungbe, I. Hambleton, L. Stephens, B. Serjeant, and G. Serjeant, “Red cell antibodies in patients with homozygous sickle cell disease: A comparison of patients in Jamaica and the United Kingdom,” British Journal of Haematology, vol. 113, no. 3, pp. 661–665, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Mohammed, B. Ahmed, J. Nasreldin, and M. Adil, “Red blood cell alloimmunization among sudanese homozygous sickle cell disease patients,” American Journal of Medicine and Medical Sciences, vol. 3, no. 4, pp. 61–67, 2013. View at Google Scholar
  28. E. Meda, P. M. Magesa, T. Marlow, C. Reid, D. J. Roberts, and J. Makani, “Red blood cell alloimmunization in sickle cell disease patients in Tanzania,” East African Journal of Public Health, vol. 11, no. 2, pp. 775–780, 2014. View at Google Scholar
  29. O. Castro, S. G. Sandler, P. Houston-Yu, and S. Rana, “Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.,” Transfusion, vol. 42, no. 6, pp. 684–690, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. P. A. Maaskant-Van Wijk, B. H. W. Faas, J. A. M. De Ruijter et al., “Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD-specific exons,” Transfusion, vol. 38, no. 11-12, pp. 1015–1021, 1998. View at Google Scholar · View at Scopus
  31. A. M. Dias Zanette, M. de Souza Gonçalves, L. Vilasboas Schettini, and etal., “Alloimmunization and clinical profile of sickle cell disease patients from Salvador-Brazil,” Ethnicity & Disease, vol. 20, no. 2, pp. 136–141, 2010. View at Google Scholar
  32. M. Murao and M. B. Viana, “Risk factors for alloimmunization by patients with sickle cell disease,” Brazilian Journal of Medical and Biological Research, vol. 38, no. 5, pp. 675–682, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Sarnaik, J. Schornack, and J. M. Lusher, “The incidence of development of irregular red cell antibodies in patients with sickle cell anemia,” Transfusion, vol. 26, no. 3, pp. 249–252, 1986. View at Publisher · View at Google Scholar · View at Scopus
  34. S. A. Campbell-Lee, K. Gvozdjan, K. M. Choi et al., “Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods,” Transfusion, 2018. View at Publisher · View at Google Scholar
  35. M. E. M. Yee, C. D. Josephson, A. M. Winkler et al., “Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia,” Transfusion, vol. 57, no. 11, pp. 2738–2746, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Allali, T. Peyrard, D. Amiranoff et al., “Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre,” British Journal of Haematology, vol. 177, no. 4, pp. 641–647, 2017. View at Publisher · View at Google Scholar · View at Scopus
  37. S. T. Singer, V. Wu, R. Mignacca, F. A. Kuypers, P. Morel, and E. P. Vichinsky, “Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent,” Blood, vol. 96, no. 10, pp. 3369–3373, 2000. View at Google Scholar · View at Scopus
  38. B. Keikhaei, A. Hirad Far, H. Abolghasemi et al., “Red blood cell alloimmunization in patients with thalassemia major and intermediate in southwest Iran,” Iranian Journal of Blood & Cancer, vol. 6, no. 1, pp. 41–46, 2013. View at Google Scholar
  39. M. Amin, “Prevalence of alloimmunization against RBC antigens in thalassemia major patients in South East Of Iran,” Journal of Blood Disorders & Transfusion, vol. 04, no. 04, 2013. View at Publisher · View at Google Scholar
  40. B. Aygun, S. Padmanabhan, C. Paley, and V. Chandrasekaran, “Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions,” Transfusion, vol. 42, no. 1, pp. 37–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. S. M. Castellino, M. R. Combs, S. A. Zimmerman, P. D. Issitt, and R. E. Ware, “Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance,” British Journal of Haematology, vol. 104, no. 1, pp. 189–194, 1999. View at Publisher · View at Google Scholar · View at Scopus